(Q42628085)

4 November 2017

title

Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2. (English)

1 reference

4 November 2017

1

1 reference

4 November 2017

publication date

1 June 2000

1 reference

4 November 2017

1 reference

4 November 2017

volume

107

1 reference

4 November 2017

issue

6

1 reference

4 November 2017

page(s)

1171-1177

1 reference

Effects of brimonidine on aqueous humor dynamics in human eyes

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900081-6

7 January 2021

Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients. Brimonidine Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900081-6

7 January 2021

Systemic drug interactions with topical glaucoma medications

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900081-6

7 January 2021

Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900081-6

7 January 2021

A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900081-6

7 January 2021

Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900081-6

7 January 2021

Interaction of Topical and Oral Timolol in Glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900081-6

7 January 2021

Systemic side effects of topical beta-adrenergic blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900081-6

7 January 2021

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900081-6

7 January 2021

10.1016/S0161-6420(00)00081-6

Identifiers

DOI

1 reference

4 November 2017

1 reference